| [1]ZK(#〗Bennett BD,Wang Z,Kuang WJ,et al.Cloning and characterization of HTK,a novel transmembrane tyrosine kinase of the EPH subfamily[J].J Biol Chem,1994,269(19):14211-14218[2]Bennett BD,Zeigler FC,Gu Q,et al.Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk[J].Proc Natl Acad Sci USA,1995,92(6):1866-1870[3]Kim I,Ryu YS,Kwak HJ,et al.EphB ligand,ephrinB2,suppresses the VEGF-and angiopoietin 1- induced Ras/ migogen- activated protein kinase pathway in venous endothelial cells[J].Faseb J,2002,16(9):1126-1128[4]Palmer A,Zimmer M,Erdmann KS,et al.EphrinB phosphorylation and reverse signaling:regulation by Src kinases and PTP-BL phosphatase[J].Mol Cell,2002,9(4):725-737[5]Zhang XQ.Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2+ endothelial cells[J].Blood,2001,98(4):1028-1037[6]Shin D,Garcia-Cardena G,Hayashi S,et al.Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells，and marks subsets of micro vessels at sites of adult neovascularization[J].Dev Biol,2001,230(2):l39-150[7]Kim YH,Hu H,Guevara-Gallardo S,et al.Artery and vein size is balanced by Notch and ephrinB2/EphB4 during angiogenesis[J].Development,2008,135(22):3755-3764[8]Wang HU,Chen ZF,Anderson DJ.Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4[J].Cell,1998,93(5):741-753[9]Erber R,Eichelsbacher U,Powajbo V,et al.EphB4 controls blood vascular morphogenesis during postnatal angiogenesis[J].EMBO J,2006,25(3):628-641[10]Adams RH,Diella F,Hennig S,et al.The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial crest migration[J].Cell,2001,104(1):57-69[11]Steinle JJ,Meininger CJ,Forough R,et al.EphB4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3- kinase pathway[J].J Biol Chem,2002,277(46):43830-43835[12]Sturz A,Bader B,Thierauch KH,et al.EphB4 signaling is capable of mediating ephrinB2- induced inhibition of cell migration[J].Biochem Biophys Res Commun,2004,313(1):80-88[13]Noren NK,Lu M,Freeman AL,et al.Interplay between EphB4 on tumor cells and vascular ephrinB2 regulates tumor growth[J].Proc Natl Acad Sci USA,2004,101(15):5583-5588[14]Wang J,Ma J,Dong Y,et al.High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease[J].APMIS,2013,121(1):30-37[15]Li D,Liu SL,Liu R,et al.Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring[J].Molecular pharmaceutics,2013,10(1):329-336[16]Li M,Zhao ZW.Clinical implications of EphB4 receptor expression in pancreatic cancer[J].Molecular Biology Reports,2013,40(2):1735-1741[17]Ma XY,Luo DF,Li KZ,et al.Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating akt phosphorylation[J].J Huazhong U Sci-Med,2012,32(3):358-363[18]Tu YY,He SM,Fu JF,et al.Expression of EphrinB2 and EphB4 in glioma t3s correlated to the progression of glioma and the prognosis of glioblastoma patients[J].Clin Transl Oncol,2012,14(3):214-220[19]Luo X,Cohen KS.Regulation of tumor immune microenvironments by Ephrinb2[J].J Invest Med,2011,59(4):697-698[20]Chen T,Liu XY,Yi SH,et al.EphB4 is overexpressed in gliomas and promotes the growth of glioma cells[J].Tumor Biol,2013,34(1):379-385[21]Li M,Zhao Z.Clinical implications of EphB4 receptor expression in pancreatic cancer[J].J Mol Biol Rep,2013,40(2):1735-1741[22]Irene GM,Antonio S,Esther MM.et alGene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab[J]..J Med Oncol,2013,30(2):572-580[23]Pietanza MC,Gadgeel SM,Dowlati A,et al.Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with Non-Small-Cell lung cancer[J].J Thorac Oncol,2012,7(5):856-865[24]Pietanza MC,Lynch TJ,Lara PN,et al.XL647-A multitargeted tyrosine kinase inhibitor results of a phase Ⅱ study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib[J].J Thorac Oncol,2012,7(1):219-226[25]Abéngozar MA,de Frutos S,Ferreiro S,et al.Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis,lymphangiogenesis,and tumor growth[J].J Blood,2012,119(19):4565-4576[26]Zin A,Gole GA.Retinopathy of prematurity-incidence today[J].J Clin Perinatol,2013,40(2):185-200[27]Umeda N,Ozaki H,Hayashi H,et al.Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases[J].J Am J Ophthalmol,2004,138(2):270-279[28]Taylor AC,Mendel TA,Mason KE,et al.Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy[J].J Invest Ophthalmol Vis Sci,2012,53(9):5462-5470[29]Ehlken C,Martin G,Lange C,et al.Therapeutic interference with EphrinB2 signalling inhibits oxygen induced angioproliferative retinopathy[J].J Acta Ophthalmol,2011,89(1):82-90[30]Zhao C,Irie N,Takada Y,et al.Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis[J].J Cell Metab,2006,4(2):111-121[31]Allan EH,Husler KD,Wei T,et al.EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts[J].J Bone Miner Res,2008,23(8):1170-1181[32]Pasquale EB.Eph-ephrin bidirectional signaling in physiology and disease[J].Cell,2008,133(1):38-52[33]Arthur A,Zannettino A,Panagopoulos R,et al.EphB/ephrin-B interactions mediate human MSC attachment,migration and osteochondral differentiation[J].J Bone,2011,48(3):533-542[34]Tierney EG,McSorley K,Hastings CL,et al.High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix[J].J Control Release,2013,165(3):173-182 |
